DYAI
Dyadic International Inc
NASDAQ: DYAI · HEALTHCARE · BIOTECHNOLOGY
$0.71
-1.77% today
Updated 2026-06-05
Market cap
$25.89M
P/E ratio
—
P/S ratio
6.80x
EPS (TTM)
$-0.21
Dividend yield
—
52W range
$1 – $1
Volume
0.3M
WallStSmart proprietary scores
23
out of 100
Grade: F
Strong Sell
Investment rating
5.3
Growth
C+6.3
Quality
B2.0
Profitability
F6.7
Valuation
B1/9
Piotroski F-Score
Weak
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$6.00
+744.48%
12-Month target
—
—
Intrinsic (DCF)
$4.76
Margin of safety
+83.29%
0 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Revenue growth 182.30% QoQ
+ 83.29% below intrinsic value
+ Debt/equity -12.39x — low leverage
Risks
- Piotroski 1/9 — weak financial health
- Thin margins at -191.50%
- Negative free cash flow $-1.96M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $2.93M | $2.90M | $3.50M | $1.23M | $3.81M |
| Net income | $-9.74M | $-6.80M | $-5.81M | $-7.36M | $-1.95M |
| EPS | — | — | — | — | $-0.21 |
| Free cash flow | $-8.08M | $-6.73M | $-3.97M | $-5.70M | $-1.96M |
| Profit margin | -332.23% | -234.42% | -166.19% | -597.63% | -191.50% |
Peer comparison
Smart narrative
Dyadic International Inc trades at $0.71. Our Smart Value Score of 23/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. TTM revenue stands at $3.81M. with profit margins at -191.50%. Our DCF model estimates intrinsic value at $4.76.
Frequently asked questions
What is Dyadic International Inc's stock price?
Dyadic International Inc (DYAI) trades at $0.71, on a P/S of 6.8x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Dyadic International Inc overvalued?
Dyadic International Inc carries a Smart Value Score of 23/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read. Our DCF puts intrinsic value at $4.76 versus the $0.71 price, a 83.3% margin of safety on a cash flow basis.
What is the price target of Dyadic International Inc (DYAI)?
The 12-month analyst consensus target is $6.00, about 744.5% above the current $0.71. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the intrinsic value of Dyadic International Inc (DYAI)?
Our DCF model estimates intrinsic value at $4.76, a +83.3% margin of safety versus today's $0.71. Intrinsic value is what the projected cash flows are worth today. A positive reading means the price sits below that estimate, leaving a cushion if growth holds.
What is Dyadic International Inc's revenue?
Dyadic International Inc's trailing twelve-month revenue is $3.81M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio6.80x
ROE-2,827.00%
Beta1.17
50D MA$0.79
200D MA$0.91
Shares out0.04B
Float0.03B
Short ratio—
Avg volume0.3M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—